- AMGN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
SC 13G/A Filing
Amgen (AMGN) SC 13G/AAtara Biotherapeutics, Inc.
Filed: 7 Feb 17, 12:00am
Exhibit 1
Joint Filing Agreement
The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the common stock of the Issuer shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.
Dated: February 7, 2017
AMGEN INC. | ||||
By: | /s/ David A. Piacquad | |||
Name: | David A. Piacquad | |||
Title: | Senior Vice President, Business Development |
AMGEN INVESTMENTS LTD. | ||||
By: | /s/ David A. Piacquad | |||
Name: | David A. Piacquad | |||
Title: | Senior Vice President, Business Development |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.